"Urology Centers of Alabama is committed to providing the highest quality urological medical services in a compassionate and caring environment. With an expert staff of urologists, urogynecologists, radiation oncologists, medical oncologist, pathologist, and a team of physicians’ assistants and nurse practitioners, UCA has earned a well-deserved reputation for excellence in the Alabama medical community."

During the past decade, Urology Centers Of Alabama conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology Centers Of Alabama" #1 sponsor was "Ferring Pharmaceuticals" with 9 trials, followed by "Abbott" with 4 trials sponsored, "GTx" with 4 trials sponsored, "Foresee Pharmaceuticals Co., Ltd." with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology Centers Of Alabama" #1 collaborator was "Accelovance" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "QPS-Qualitix" with 1 trials as a collaborator and "Therion Biologics Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Urology Centers Of Alabama" are "Prostate Cancer" (19 trials), "Prostatic Neoplasms" (6 trials), "Overactive Bladder" (3 trials), "Stress Urinary Incontinence" (3 trials) and "Androgen-insensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Urology Centers Of Alabama" in a lesser frequency.

Most popular intervention types in "Urology Centers Of Alabama" are "Drug" (31 trials), "Biological" (5 trials), "Other" (3 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (8 trials), "Placebo" (4 trials), "Atrasentan" (3 trials), "GTx-024" (2 trials) and "Leuprolide Mesylate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Urology Centers Of Alabama" are 34 trials for "Male" genders, 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Urology Centers Of Alabama". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Urology Centers Of Alabama, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Urology Centers Of Alabama, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".